Clindamycin: A Trojan Horse?
- 1 April 1975
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 101 (4) , 235-237
- https://doi.org/10.1001/archotol.1975.00780330031008
Abstract
Clindamycin is a widely used antibiotic with a spectrum that includes Gram-positive bacteria, with the exception of enterococci, and Gram-negative anaerobes. Toxicities include clindamycin colitis, a pseudomembranous colitis that can be fatal. The colitis usually is related to dosage and duration of therapy, but can occur after ingestion of only several capsules. Once diarrhea develops in a patient taking clindamycin, the drug should be stopped and diagnostic measures to define colitis initiated. If colitis is present, it should be managed aggressively, probably with corticosteroids and with intensive supportive measures.Keywords
This publication has 8 references indexed in Scilit:
- ChemInform Abstract: CHEMICAL MODIFICATION OF LINCOMYCIN, SYNTHESIS AND BIOACTIVITY OF SELECTED 2,7-DIALKYLCARBONATE ESTERSChemischer Informationsdienst, 1974
- Diagnostic Features of Clindamycin-Associated Pseudomembranous ColitisNew England Journal of Medicine, 1974
- LINCOMYCIN AND PSEUDOMEMBRANOUS COLITISThe Lancet, 1974
- A Reappearance of Antibiotic-Induced Pseudomembranous EnterocolitisRadiology, 1974
- Anaerobic Infection of the Paranasal SinusesNew England Journal of Medicine, 1974
- Pseudomembranous colitis: a consideration in the barium enema differential diagnosis of acute generalized ulcerative colitisThe British Journal of Radiology, 1973
- In Vitro Antimicrobial Susceptibility of Anaerobic Bacteria Isolated from Clinical SpecimensAntimicrobial Agents and Chemotherapy, 1972
- LincomycinPediatric Clinics of North America, 1968